Close Menu

NEW YORK (GenomeWeb) – Gene editing technology company Inscripta announced today that its existing investors have agreed to contribute an additional $30 million to its Series C funding round, bringing the total raised in the round to $85.5 million.

In February, the company said it had raised $55.5 million from Venrock, Foresite, Mérieux Développement, Paladin Capital Group, MLS Capital, and NanoDimension. The same investors contributed the additional funding.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Hill reports President Donald Trump issued an executive directing federal agencies to cut the number of board and advisory committees they have.

The New York Times reports that researchers are combining tools to more quickly develop crops to feed a growing population and cope with shifting climates.

Scientists in Canada are looking to the UK's plan to sequence children with rare conditions for inspiration, the National Post reports.

In PNAS this week: copy number changes arose during polar bear evolution, genomic and transcriptomic analysis of the Siberian hamster, and more.